Literature DB >> 19297503

Polyfunctional CD4+ T-cell induction in neutralizing antibody-triggered control of simian immunodeficiency virus infection.

Takuya Yamamoto1, Nami Iwamoto, Hiroyuki Yamamoto, Tetsuo Tsukamoto, Tetsuya Kuwano, Akiko Takeda, Miki Kawada, Yasuko Tsunetsugu-Yokota, Tetsuro Matano.   

Abstract

Rapid depletion of memory CD4(+) T cells and delayed induction of neutralizing antibody (NAb) responses are characteristics of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections. Although it was speculated that postinfection NAb induction could have only a limited suppressive effect on primary HIV replication, a recent study has shown that a single passive NAb immunization of rhesus macaques 1 week after SIV challenge can result in reduction of viral loads at the set point, indicating a possible contribution of postinfection NAb responses to virus control. However, the mechanism accounting for this NAb-triggered SIV control has remained unclear. Here, we report rapid induction of virus-specific polyfunctional T-cell responses after the passive NAb immunization postinfection. Analysis of SIV Gag-specific responses of gamma interferon, tumor necrosis factor alpha, interleukin-2, macrophage inflammatory protein 1beta, and CD107a revealed that the polyfunctionality of Gag-specific CD4(+) T cells, as defined by the multiplicity of these responses, was markedly elevated in the acute phase in NAb-immunized animals. In the chronic phase, despite the absence of detectable NAbs, virus control was maintained, accompanied by polyfunctional Gag-specific T-cell responses. These results implicate virus-specific polyfunctional CD4(+) T-cell responses in this NAb-triggered virus control, suggesting possible synergism between NAbs and T cells for control of HIV/SIV replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297503      PMCID: PMC2681982          DOI: 10.1128/JVI.00145-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.

Authors:  J R Mascola; G Stiegler; T C VanCott; H Katinger; C B Carpenter; C E Hanson; H Beary; D Hayes; S S Frankel; D L Birx; M G Lewis
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay.

Authors:  John T Loffredo; Eva G Rakasz; Juan Pablo Giraldo; Sean P Spencer; Kelly K Grafton; Sarah R Martin; Gnankang Napoé; Levi J Yant; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

Authors:  Qingsheng Li; Lijie Duan; Jacob D Estes; Zhong-Min Ma; Tracy Rourke; Yichuan Wang; Cavan Reilly; John Carlis; Christopher J Miller; Ashley T Haase
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

Authors:  A C McNeil; W L Shupert; C A Iyasere; C W Hallahan; J A Mican; R T Davey; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

7.  Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

Authors:  John J Zaunders; Mee Ling Munier; Daniel E Kaufmann; Susanna Ip; Pat Grey; Don Smith; Tim Ramacciotti; Dick Quan; Robert Finlayson; John Kaldor; Eric S Rosenberg; Bruce D Walker; David A Cooper; Anthony D Kelleher
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

8.  Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.

Authors:  P W Parren; P A Marx; A J Hessell; A Luckay; J Harouse; C Cheng-Mayer; J P Moore; D R Burton
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

10.  Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection.

Authors:  Marie-Claire Gauduin; Yi Yu; Amy Barabasz; Angela Carville; Mike Piatak; Jeffrey D Lifson; Ronald C Desrosiers; R Paul Johnson
Journal:  J Exp Med       Date:  2006-11-20       Impact factor: 14.307

View more
  23 in total

1.  Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques.

Authors:  J Pablo Jaworski; James Kobie; Zachary Brower; Delphine C Malherbe; Gary Landucci; William F Sutton; Biwei Guo; Jason S Reed; Enrique J Leon; Flora Engelmann; Bo Zheng; Al Legasse; Byung Park; Mary Dickerson; Anne D Lewis; Lois M A Colgin; Michael Axthelm; Ilhem Messaoudi; Jonah B Sacha; Dennis R Burton; Donald N Forthal; Ann J Hessell; Nancy L Haigwood
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

2.  Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.

Authors:  Kazutaka Terahara; Hiroshi Ishii; Takushi Nomura; Naofumi Takahashi; Akiko Takeda; Teiichiro Shiino; Yasuko Tsunetsugu-Yokota; Tetsuro Matano
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 3.  Immunodeficiency lentiviral infections in natural and non-natural hosts.

Authors:  Jason M Brenchley; Mirko Paiardini
Journal:  Blood       Date:  2011-04-19       Impact factor: 22.113

Review 4.  Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1.

Authors:  Yoshiaki Nishimura; Malcolm A Martin
Journal:  Cell Host Microbe       Date:  2017-08-09       Impact factor: 21.023

5.  Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques.

Authors:  Takushi Nomura; Hiroyuki Yamamoto; Teiichiro Shiino; Naofumi Takahashi; Taku Nakane; Nami Iwamoto; Hiroshi Ishii; Tetsuo Tsukamoto; Miki Kawada; Saori Matsuoka; Akiko Takeda; Kazutaka Terahara; Yasuko Tsunetsugu-Yokota; Naoko Iwata-Yoshikawa; Hideki Hasegawa; Tetsutaro Sata; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

6.  A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses.

Authors:  Daniela Santoro Rosa; Susan Pereira Ribeiro; Rafael Ribeiro Almeida; Eliane Conti Mairena; Edilberto Postól; Jorge Kalil; Edecio Cunha-Neto
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

7.  Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.

Authors:  Han Kang; Qin Yuan; Hui Ma; Zhi-Dong Hu; De-Ping Han; Kang Wu; Douglas B Lowrie; Xiao-Yong Fan
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

8.  Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.

Authors:  Sumire Iseda; Naofumi Takahashi; Hugo Poplimont; Takushi Nomura; Sayuri Seki; Taku Nakane; Midori Nakamura; Shoi Shi; Hiroshi Ishii; Shota Furukawa; Shigeyoshi Harada; Taeko K Naruse; Akinori Kimura; Tetsuro Matano; Hiroyuki Yamamoto
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

9.  HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells.

Authors:  Bingbing Dai; Lili Yang; Haiguang Yang; Biliang Hu; David Baltimore; Pin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

10.  Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children.

Authors:  Stefano Rinaldi; Suresh Pallikkuth; Mark Cameron; Lesley R de Armas; Nicola Cotugno; Vinh Dinh; Rajendra Pahwa; Brian Richardson; Shelly R Saini; Salvatore Rocca; Maria G Lain; Sion L Williams; Paolo Palma; Savita Pahwa
Journal:  J Immunol       Date:  2019-12-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.